We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image Credit: iStock

Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

A new blood test analyzes rare cells and vesicles to complement mammography and detect Stage I breast cancer. More...
20 Oct 2026
Image: Cell culture of induced pluripotent stem cells (iPSCs). Neurons are shown in green and astrocytes in red. (Photo courtesy of Carlos Avilés Granados)

CSF Biomarker Meprin-Beta Increases in Alzheimer’s Disease

New findings show elevated active meprin-β in brain and CSF in Alzheimer’s disease, suggesting utility as a biomarker. More...
20 Oct 2026
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

New data forecast the cancer diagnostics market to reach USD 41.5B by 2031 at 7.2% CAGR amid growth in IVDs and liquid biopsy More...
20 Oct 2026
Image Credit: 123RF

Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

WHO grants Emergency Use Listing to a molecular panel for testing Ebola and other high-risk pathogens from whole blood. More...
20 Oct 2026
Image: The MyChoice CDx test, currently used as a companion diagnostic in ovarian cancer, will generate the PrGIS score and is being advanced for use in prostate cancer. (Photo courtesy of Myriad Genetics)

Collaboration Advances Genomic Instability Biomarker for Prostate Cancer

A new collaboration aims to advance a prostate cancer genomic instability score for clinical trials and companion diagnostics. More...
20 Oct 2026
IMage: Labcorp will acquire BioReference Health’s 4Kscore Test, an FDA-approved blood test that helps predict the likelihood of aggressive prostate cancer before biopsy. (Photo courtesy of OPKO Health

Labcorp Acquisition to Strengthen Specialty Testing and Prostate Cancer Assessment

Labcorp has entered into an agreement with OPKO Health to acquire select assets of BioReference Health. More...
20 Oct 2026
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

NeoGenomics has expanded its partnership with Indica Labs to scale AI-powered digital pathology across its enterprise. More...
20 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Copyright © 2000-2026 Globetech Media. All rights reserved.